Analgesics
Antiandrogens
Azvudine
Bromhexine
Budesonide
Colchicine
Conv. Plasma
Curcumin
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Ivermectin
Lifestyle
Melatonin
Metformin
Minerals
Molnupiravir
Monoclonals
Naso/orophar..
Nigella Sativa
Nitazoxanide
Paxlovid
Quercetin
Remdesivir
Thermotherapy
Vitamins
More

Other
Feedback
Home
Top
Abstract
All ivermectin studies
Meta analysis
 
Feedback
Home
next
study
previous
study
c19ivm.org COVID-19 treatment researchIvermectinIvermectin (more..)
Melatonin Meta
Metformin Meta
Azvudine Meta
Bromhexine Meta Molnupiravir Meta
Budesonide Meta
Colchicine Meta
Conv. Plasma Meta Nigella Sativa Meta
Curcumin Meta Nitazoxanide Meta
Famotidine Meta Paxlovid Meta
Favipiravir Meta Quercetin Meta
Fluvoxamine Meta Remdesivir Meta
Hydroxychlor.. Meta Thermotherapy Meta
Ivermectin Meta

All Studies   Meta Analysis    Recent:   

Increase in Outpatient Ivermectin Dispensing in the US During the COVID-19 Pandemic: A Cross-Sectional Analysis

Lind et al., Journal of General Internal Medicine, doi:10.1007/s11606-021-06948-6
Jun 2021  
  Post
  Facebook
Share
  Source   PDF   All Studies   Meta AnalysisMeta
Ivermectin for COVID-19
4th treatment shown to reduce risk in August 2020
 
*, now with p < 0.00000000001 from 104 studies, recognized in 22 countries.
No treatment is 100% effective. Protocols combine treatments. * >10% efficacy, ≥3 studies.
4,300+ studies for 75 treatments. c19ivm.org
CDC analysis of ivermectin prescriptions in the US suggesting that, while national health authority recognition is delayed in that country, many physicians are aware of the efficacy demonstrated in clinical trials.
Reviews covering ivermectin for COVID-19 include1-38.
Lind et al., 18 Jun 2021, peer-reviewed, 6 authors.
This PaperIvermectinAll
Abstract: Increase in Outpatient Ivermectin Dispensing in the US During the COVID-19 Pandemic: A Cross-Sectional Analysis J Gen Intern Med 36(9):2909–11 DOI: 10.1007/s11606-021-06948-6 © This is a U.S. government work and not under copyright protection in the U.S.; foreign copyright protection may apply 2021
{ 'indexed': {'date-parts': [[2024, 5, 8]], 'date-time': '2024-05-08T20:34:21Z', 'timestamp': 1715200461381}, 'reference-count': 6, 'publisher': 'Springer Science and Business Media LLC', 'issue': '9', 'license': [ { 'start': { 'date-parts': [[2021, 6, 18]], 'date-time': '2021-06-18T00:00:00Z', 'timestamp': 1623974400000}, 'content-version': 'tdm', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}, { 'start': { 'date-parts': [[2021, 6, 18]], 'date-time': '2021-06-18T00:00:00Z', 'timestamp': 1623974400000}, 'content-version': 'vor', 'delay-in-days': 0, 'URL': 'https://www.springer.com/tdm'}], 'content-domain': {'domain': ['link.springer.com'], 'crossmark-restriction': False}, 'published-print': {'date-parts': [[2021, 9]]}, 'DOI': '10.1007/s11606-021-06948-6', 'type': 'journal-article', 'created': {'date-parts': [[2021, 6, 18]], 'date-time': '2021-06-18T18:02:40Z', 'timestamp': 1624039360000}, 'page': '2909-2911', 'update-policy': 'http://dx.doi.org/10.1007/springer_crossmark_policy', 'source': 'Crossref', 'is-referenced-by-count': 22, 'title': 'Increase in Outpatient Ivermectin Dispensing in the US During the COVID-19 Pandemic: A ' 'Cross-Sectional Analysis', 'prefix': '10.1007', 'volume': '36', 'author': [ { 'ORCID': 'http://orcid.org/0000-0002-7408-3318', 'authenticated-orcid': False, 'given': 'Jennifer N.', 'family': 'Lind', 'sequence': 'first', 'affiliation': []}, {'given': 'Maribeth C.', 'family': 'Lovegrove', 'sequence': 'additional', 'affiliation': []}, {'given': 'Andrew I.', 'family': 'Geller', 'sequence': 'additional', 'affiliation': []}, {'given': 'Timothy M.', 'family': 'Uyeki', 'sequence': 'additional', 'affiliation': []}, {'given': 'S. Deblina', 'family': 'Datta', 'sequence': 'additional', 'affiliation': []}, {'given': 'Daniel S.', 'family': 'Budnitz', 'sequence': 'additional', 'affiliation': []}], 'member': '297', 'published-online': {'date-parts': [[2021, 6, 18]]}, 'reference': [ { 'key': '6948_CR1', 'doi-asserted-by': 'publisher', 'first-page': '104787', 'DOI': '10.1016/j.antiviral.2020.104787', 'volume': '178', 'author': 'L Caly', 'year': '2020', 'unstructured': 'Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA-approved drug ' 'ivermectin inhibits the replication of SARS-CoV-2 in vitro. Antiviral ' 'Res. 2020;178:104787.', 'journal-title': 'Antiviral Res.'}, { 'key': '6948_CR2', 'unstructured': 'National Institutes of Health COVID-19 Treatment Guidelines Panel. ' 'Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. Available at: ' 'https://www.covid19treatmentguidelines.nih.gov/antiviral-therapy/ivermectin. ' 'Accessed 11 Feb 2021.'}, { 'key': '6948_CR3', 'unstructured': 'IQVIA. Prescription Information. Available at: ' 'https://www.iqvia.com/locations/united-states/solutions/commercial-operations/essential-information/prescription-information. ' 'Accessed 20 Jan 2021.'}, { 'key': '6948_CR4', 'unstructured': 'United States Government. Federal Regulations and Codes. See e.g., 45 ' 'C.F.R. part 46.102(l)(2), 21 C.F.R. part 56; 42 U.S.C. §241(d); 5 U.S.C. ' '§552a; 44 U.S.C. §3501 et seq.'}, { 'key': '6948_CR5', 'unstructured': 'Centers for Disease Control and Prevention. COVID Data Tracker. ' 'Available at: ' 'https://covid.cdc.gov/covid-data-tracker/#trends_dailytrendscases. ' 'Accessed 6 May 2021.'}, { 'key': '6948_CR6', 'unstructured': 'US Food and Drug Administration. Why You Should Not Use Ivermectin to ' 'Treat or Prevent COVID-19. Available at: ' 'https://www.fda.gov/consumers/consumer-updates/why-you-should-not-use-ivermectin-treat-or-prevent-covid-19?utm_medium=email&utm_source=govdelivery. ' 'Accessed 12 Apr 2021.'}], 'container-title': 'Journal of General Internal Medicine', 'original-title': [], 'language': 'en', 'link': [ { 'URL': 'https://link.springer.com/content/pdf/10.1007/s11606-021-06948-6.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/article/10.1007/s11606-021-06948-6/fulltext.html', 'content-type': 'text/html', 'content-version': 'vor', 'intended-application': 'text-mining'}, { 'URL': 'https://link.springer.com/content/pdf/10.1007/s11606-021-06948-6.pdf', 'content-type': 'application/pdf', 'content-version': 'vor', 'intended-application': 'similarity-checking'}], 'deposited': { 'date-parts': [[2022, 6, 17]], 'date-time': '2022-06-17T23:04:07Z', 'timestamp': 1655507047000}, 'score': 1, 'resource': {'primary': {'URL': 'https://link.springer.com/10.1007/s11606-021-06948-6'}}, 'subtitle': [], 'short-title': [], 'issued': {'date-parts': [[2021, 6, 18]]}, 'references-count': 6, 'journal-issue': {'issue': '9', 'published-print': {'date-parts': [[2021, 9]]}}, 'alternative-id': ['6948'], 'URL': 'http://dx.doi.org/10.1007/s11606-021-06948-6', 'relation': {}, 'ISSN': ['0884-8734', '1525-1497'], 'subject': [], 'container-title-short': 'J GEN INTERN MED', 'published': {'date-parts': [[2021, 6, 18]]}, 'assertion': [ { 'value': '16 March 2021', 'order': 1, 'name': 'received', 'label': 'Received', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '20 May 2021', 'order': 2, 'name': 'accepted', 'label': 'Accepted', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, { 'value': '18 June 2021', 'order': 3, 'name': 'first_online', 'label': 'First Online', 'group': {'name': 'ArticleHistory', 'label': 'Article History'}}, {'order': 1, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Declarations'}}, { 'value': 'The authors declare that they do not have a conflict of interest.', 'order': 2, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Conflict of Interest'}}, { 'value': 'The findings and conclusions in this report are those of the authors and do not ' 'necessarily represent the official position of the Centers for Disease Control ' 'and Prevention.', 'order': 3, 'name': 'Ethics', 'group': {'name': 'EthicsHeading', 'label': 'Disclaimer'}}, { 'value': 'This content has been made available to all.', 'name': 'free', 'label': 'Free to read'}]}
Loading..
Please send us corrections, updates, or comments. c19early involves the extraction of 100,000+ datapoints from thousands of papers. Community updates help ensure high accuracy. Treatments and other interventions are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit